Advanced search×

Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.

Haematologica 96(8):1113-20 (2011) PMID 21508120

Allogeneic hematopoietic cell transplantation is a potentially curative treatment for patients with acute lymphoblastic leukemia. However, the majority of older adults with acute lymphoblastic leukemia are not candidates for myeloablative conditioning regimens. A non-myeloablative preparative regimen is a reasonable treatment option for this group. We sought to determine the outcome of non-myeloablative conditioning and allogeneic transplantation in patients with high-risk acute lymphoblastic leukemia.

DOI: 10.3324/haematol.2011.040261
Version: za2963e q8za8 q8zbb q8zc6 q8zd1 q8ze2 q8zf7 q8zg1

Similar articles you may find interesting…

  1. Malignant hematologic diseases in adolescents and young adults.

    Blood 117(22):5803-15 (2011) PMID 21398581

    Adolescents and young adults (AYA) with cancer have been designated as a vulnerable population by the NCI. This group, defined by the ages of 16-39 years, has not enjoyed the same survival improvements over the last several decades as older and younger cohorts. Several barriers preve...
  2. Hematopoietic cell transplantation with autologous cord blood in patients with severe aplastic anemia: an opportunity to revisit the controv...

    Pediatr Blood Cancer 56(7):1009-12 (2011) PMID 21370429

    The controversy surrounding private banking of umbilical cord blood units (CBU), as a safeguard against future malignancy or other life-threatening conditions, raises many questions in pediatric clinical practice. Recent favorable experiences with autologous transplantation for severe aplastic anemia...
  3. Hematopoietic cell transplantation with autologous cord blood in patients with severe aplastic anemia: an opportunity to revisit the controv...

    Pediatr Blood Cancer 56(7):1009-12 (2011) PMID 21370429

    The controversy surrounding private banking of umbilical cord blood units (CBU), as a safeguard against future malignancy or other life-threatening conditions, raises many questions in pediatric clinical practice. Recent favorable experiences with autologous transplantation for sever...